Citation Impact
Citing Papers
Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes
2015 Standout
Depot-specific differences in perilipin and hormone-sensitive lipase expression in lean and obese
2009
Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants
2016 Standout
The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice
2003
Hepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorption are associated with insulin requirements during insulin therapy in type 2 diabetic patients.
2000
Effects of surgical treatment of the metabolic syndrome on liver fibrosis and cirrhosis
2003
Regional differences in adipose tissue metabolism in obese men
2007
Thiazolidinediones
2004 Standout
Clinical and pathophysiological consequences of abdominal adiposity and abdominal adipose tissue depots
2003
Abdominal obesity and metabolic syndrome
2006 StandoutNature
Nonalcoholic Fatty Liver Disease: From Steatosis to Cirrhosis
2006 Standout
Role of AMP-activated protein kinase in mechanism of metformin action
2001 Standout
Chronic inflammation in the etiology of disease across the life span
2019 Standout
Nonalcoholic fatty liver disease
2002
Left ventricular hypertrophy and QT interval in obesity and in hypertension: effects of weight loss and of normalisation of blood pressure
2004
Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population
2004
Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity
2012 StandoutNature
Fat Accumulation in the Liver Is Associated with Defects in Insulin Suppression of Glucose Production and Serum Free Fatty Acids Independent of Obesity in Normal Men
2002
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
2005 Standout
The metabolic syndrome
2010 Standout
The Metabolic Syndrome X
1999
Bariatric Surgery
2004 Standout
Nonalcoholic Fatty Liver Disease
2002 Standout
Insulin resistance, iron, and the liver
2000
Non‐alcoholic fatty liver syndrome: A hepatic consequence of common metabolic diseases
2003
Regional differences of insulin action in adipose tissue: insights from in vivo and in vitro studies
2005
Lifestyle, Diabetes, and Cardiovascular Risk Factors 10 Years after Bariatric Surgery
2004 Standout
Plasma Ghrelin Levels after Diet-Induced Weight Loss or Gastric Bypass Surgery
2002 Standout
Glucose transporter 4 and insulin receptor substrate–1 messenger RNA expression in omental and subcutaneous adipose tissue in women
2009
Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 5-Year Outcomes
2017 Standout
Interim results of a pilot study demonstrating the early effects of the PPAR-γ ligand rosiglitazone on insulin sensitivity, aminotransferases, hepatic steatosis and body weight in patients with non-alcoholic steatohepatitis
2003
Adipocytes as regulators of energy balance and glucose homeostasis
2006 StandoutNature
Influence of obesity and insulin sensitivity on insulin signaling genes in human omental and subcutaneous adipose tissue
2007
The changing landscape of atherosclerosis
2021 StandoutNature
Effect of Rosiglitazone on Insulin Sensitivity and Body Composition in Type 2 Diabetic Patients
2002
Long-Term Mortality after Gastric Bypass Surgery
2007 Standout
Cardiac Abnormalities as a New Manifestation of Nonalcoholic Fatty Liver Disease: Echocardiographic and Tissue Doppler Imaging Assessment
2006
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
2008 Standout
Glucose uptake and insulin action in human adipose tissue—influence of BMI, anatomical depot and body fat distribution
2002
Update on Nonalcoholic Fatty Liver Disease
2002
Mechanisms of NAFLD development and therapeutic strategies
2018 Standout
Liver fibrosis in overweight patients
2000
Weight loss after bariatric surgery improves aortic elastic properties and left ventricular function in individuals with morbid obesity: a 3-year follow-up study
2007
Insulin resistance and the pathogenesis of nonalcoholic fatty liver disease
2004
NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome
2002
The metabolic syndrome
2005 Standout
Current status of medical and surgical therapy for obesity
2001
Ninety patients with nonalcoholic steatohepatitis: insulin resistance, familial tendency, and severity of disease
2001
Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy
2006 Standout
Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association
2021 Standout
Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis
2001
Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease
2005 Standout
Endoplasmic Reticulum Stress and the Inflammatory Basis of Metabolic Disease
2010 Standout
Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 3-Year Outcomes
2014 Standout
Lipoprotein lipase steady-state mRNA levels are lower in human omental versus subcutaneous abdominal adipose tissue
2000
Inhibition of apolipoprotein B100 secretion by lipid-induced hepatic endoplasmic reticulum stress in rodents
2008
Clinical Management After Bariatric Surgery: Value of a Multidisciplinary Approach
2006
Effect of Laparoscopic Roux-En Y Gastric Bypass on Type 2 Diabetes Mellitus
2003
Global and societal implications of the diabetes epidemic
2001 StandoutNature
Bariatric Surgery versus Intensive Medical Therapy in Obese Patients with Diabetes
2012 Standout
Mechanisms linking obesity to insulin resistance and type 2 diabetes
2006 StandoutNature
Contribution of metabolic factors to alanine aminotransferase activity in persons with other causes of liver disease
2005
Is visceral obesity the cause of the metabolic syndrome?
2006
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
2002 StandoutNobel
Histopathology of Pediatric Nonalcoholic Fatty Liver Disease * #
2005
Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
2010 Standout
Metformin reverses fatty liver disease in obese, leptin-deficient mice
2000
Surgical Intervention as a Strategy for Treatment of Obesity
2000
Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: Further evidence for an etiologic association
2002
Mechanisms of fatty acid-induced inhibition of glucose uptake.
1994 Standout
Outcome of Pregnancies after Biliopancreatic Diversion
2004
Predictors of outcome in treatment of morbid obesity by laparoscopic adjustable gastric banding: results of a prospective study of 380 patients
2008
Lessons from animal models of NASH
2005
Association of nonalcoholic fatty liver disease with insulin resistance
1999
Association between nonalcoholic fatty liver disease and carotid intima-media thickness according to the presence of metabolic syndrome
2008
Potential of Surgery for Curing Type 2 Diabetes Mellitus
2002
Glucose transport is equally sensitive to insulin stimulation, but basal and insulin-stimulated transport is higher, in human omental compared with subcutaneous adipocytes
2005
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
2010 Standout
Prevalence of primary non‐alcoholic fatty liver disease in a population‐based study and its association with biochemical and anthropometric measures
2006
Noradrenaline-induced lipolysis in isolated mesenteric, omental and subcutaneous adipocytes from obese subjects
1997
Insulin Resistance: A Metabolic Pathway to Chronic Liver Disease *
2005
Effect of Duodenal–Jejunal Exclusion in a Non-obese Animal Model of Type 2 Diabetes
2003
Mechanisms of non-alcoholic steatohepatitis
2004
Management of failed adjustable gastric banding
2004
Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis
2010
Non‐alcoholic steatohepatitis: What is it, and why is it important in the Asia–Pacific region?
2003
Interaction of obesity, metabolic syndrome and Framingham risk on steatohepatitis among healthy Taiwanese: population-based nested case-control study
2006
Comparison of Hormone-Sensitive Lipase Activity in Visceral and Subcutaneous Human Adipose Tissue1
1997
Bariatric Surgery and Cardiovascular Risk Factors
2011
Pathophysiology of Human Visceral Obesity: An Update
2013 Standout
2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults
2013 Standout
Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss
2005 Standout
Body Fat Distribution and Risk of Cardiovascular Disease
2012
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
2002 StandoutNobel
Effect of Laparoscopic Sleeve Gastrectomy vs Laparoscopic Roux-en-Y Gastric Bypass on Weight Loss in Patients With Morbid Obesity
2018 Standout
Type 2 diabetes: principles of pathogenesis and therapy
2005 Standout
Nonalcoholic Fatty Liver Disease
2001 Standout
Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals
2013
Waist Girth Does Not Predict Metabolic Complications in Severely Obese Men
2006
Assessing Adiposity
2011
A Transgenic Model of Visceral Obesity and the Metabolic Syndrome
2001 StandoutScience
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Visceral Adipocyte Hypertrophy is Associated With Dyslipidemia Independent of Body Composition and Fat Distribution in Women
2011
A Bariatric Surgery Algorithm
2002
Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis
2007 Standout
Fatty Liver
2007
Regional Differences in Adipose Tissue Metabolism in Women
2006
Subcutaneous and Visceral Adipose Tissue: Their Relation to the Metabolic Syndrome
2000 Standout
Sex Differences in Visceral Fat Lipolysis and Metabolic Complications of Obesity
1997
Nonalcoholic Fatty Liver Disease: Pathologic Patterns and Biopsy Evaluation in Clinical Research
2012
Human Fatty Liver Disease: Old Questions and New Insights
2011 StandoutScience
Abdominal Visceral and Subcutaneous Adipose Tissue Compartments
2007 Standout
Variation in adrenergic regulation of lipolysis between omental and subcutaneous adipocytes from obese and non-obese men
1997
Mitogen-Activated Protein Kinases, Inhibitory-κB Kinase, and Insulin Signaling in Human Omental Versus Subcutaneous Adipose Tissue in Obesity
2007
Nonalcoholic Fatty Liver Disease
2015 Standout
Increased Lipolysis and Decreased Leptin Production by Human Omental as Compared With Subcutaneous Preadipocytes
2002
Mitochondrial Dysfunction in the Elderly: Possible Role in Insulin Resistance
2003 StandoutScience
Obesity-Associated Liver Disease
2008
Glucocorticoids Down-Regulate Glucose Uptake Capacity and Insulin-Signaling Proteins in Omental But Not Subcutaneous Human Adipocytes
2004
Works of S. Biron being referenced
Regional variation in adipose tissue insulin action and GLUT4 glucose transporter expression in severely obese premenopausal women
1997
Liver Pathology and the Metabolic Syndrome X in Severe Obesity
1999
Biliopancreatic Diversion with Duodenal Switch
1998
Regional variation in adipose tissue metabolism of severely obese premenopausal women.
1995